biote Corp. (NASDAQ:BTMD) Shares Acquired by Rhumbline Advisers

Rhumbline Advisers boosted its stake in shares of biote Corp. (NASDAQ:BTMD) by 104.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,225 shares of the company’s stock after purchasing an additional 14,404 shares during the period. Rhumbline Advisers’ holdings in biote were worth $211,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bandera Partners LLC lifted its stake in shares of biote by 7.5% during the fourth quarter. Bandera Partners LLC now owns 1,832,732 shares of the company’s stock worth $9,054,000 after purchasing an additional 127,410 shares in the last quarter. SW Investment Management LLC increased its holdings in shares of biote by 3.5% in the 4th quarter. SW Investment Management LLC now owns 675,000 shares of the company’s stock worth $3,334,000 after acquiring an additional 22,651 shares during the period. Skylands Capital LLC grew its holdings in biote by 36.2% in the 2nd quarter. Skylands Capital LLC now owns 160,845 shares of the company’s stock worth $1,202,000 after buying an additional 42,729 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of biote by 59.0% during the second quarter. Bank of New York Mellon Corp now owns 94,318 shares of the company’s stock valued at $705,000 after purchasing an additional 34,999 shares in the last quarter. Finally, Sanders Morris Harris LLC acquired a new position in shares of biote during the second quarter valued at approximately $585,000. 21.68% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at biote

In other news, CFO Robert Charles Peterson sold 11,376 shares of the company’s stock in a transaction dated Tuesday, July 9th. The stock was sold at an average price of $7.57, for a total transaction of $86,116.32. Following the completion of the sale, the chief financial officer now owns 32,874 shares in the company, valued at approximately $248,856.18. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 13.90% of the company’s stock.

biote Trading Up 4.0 %

Shares of biote stock opened at $5.67 on Friday. The stock has a market cap of $351.74 million, a PE ratio of 51.55 and a beta of 0.94. biote Corp. has a 52 week low of $3.65 and a 52 week high of $8.44. The company’s 50-day moving average price is $6.37 and its two-hundred day moving average price is $6.41.

biote (NASDAQ:BTMD) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.14 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.05. The firm had revenue of $49.17 million during the quarter, compared to analyst estimates of $50.40 million. biote had a net margin of 3.67% and a negative return on equity of 20.92%. On average, equities analysts predict that biote Corp. will post 0.52 EPS for the current fiscal year.

About biote

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.